Ossifying fibroma is a slow-growing, asymptomatic, and benign fibro-osseous lesion of the jaw. It is most commonly seen in the third and fourth decades of life, with a female predilection [1] , and 70-80% of cases occur in the premolar and molar area of the mandible [2] [3] [4] . Several rare cases involving large areas of the nasal bones, orbit, ethmoid sinus, sphenoid sinus, maxillary sinus, occiput, temporal bone, and nasopharynx have also been reported [5] . Radiographically, ossifying fibroma is radiolucent with varying degrees of opacity, and sometimes has a sclerotic border. It shows a variable appearance depending on the maturation or the amount of calcification present.
Postoperatively, the exposed bony defect has a need for soft tissue repair. This small bony defect can be covered with adjacent tissue by primary closure.
In larger bare bone defects, there are frequent complications in grasping the adjacent tissue for repairing. The insufficient vestibular depth may leave problems in dental prosthetics and oral hygiene care. This report describes a case of ossifying fibroma in the mandible. An artificial dermis was used to repair the surgical defect and showed the advantage of avoiding the vestibular insufficiency.
CASE PRESENTATION
A 24-year-old male was referred to our department for evaluation of soft tissue mass in the right side of the gingiva in the mandible. The patient stated that the lesion had been present for approximately 2 years, and had slowly enlarged after extraction of the right lower first molar. However, he was unaware that a residual root had been left in the extraction site. Except for occasionally interfering with mastication, the lesion was essentially asymptomatic. Intraoral examination revealed a nodular mass of tissue occupying the gingiva at the premolar and molar area of the right mandible. It was pink, firm, pedunculated, with an ulcerative surface ( Figure 1 ). The tumor measured approximately 25 mm in mesiodistal dimension, 15 mm buccolingually, and 10 mm occlusogingivally. A panoramic radiograph showed a well-defined radiolucent lesion containing some radio-opaque focus with a residual root of the first molar ( Figure 2 ). Computed tomography (CT) disclosed a low-bone-density-like mass within the scant soft tissue component ( Figure 3 ). CT also revealed the origin of the mass at the extraction site of the right lower first molar. The buccal and lingual cortices were expanded and perforated at the site of tooth extraction. Under local anesthesia, the pathologic report with incision biopsy indicated an ossifying fibroma. Surgical resection of the tumor was suggested and planned for the patient.
Under general anesthesia, the tumor and the overlying mucosa were excised down to the base along with the extraction of the second premolar. The residual bony base was trimmed to leave a 25 × 10 mm exposed bony defect. The surgical defect was covered with an artificial dermis graft (Terudermis™; Terumo Corp., Tokyo, Japan) ( Figure 4 ). The artificial dermis was cut to fit the dimensions of the exposed area and sutured with the mucous border. A resin plate was used to immobilize the artificial graft and to keep close contact with the host bone. The pathologic report diagnosed the specimen as an ossifying fibroma. Microscopically, there was a prominent area of highly cellular fibrous connective tissue containing foci of woven bone, osteoid and amorphous calcifications. The resin plate was smoothly removed on the 10 th postoperative day. When the silicone layer of the artificial graft was removed, the surface of the alveolar bone was totally covered by regenerated granulation tissue. One month after the operation, the granulation tissue was completely epithelialized with little contraction. After 6 years of follow-up, there was no visual or radiographic evidence of recurrence of the tumor and vestibular morphology looked satisfactory ( Figure 5 ).
DISCUSSION
Treatment of ossifying fibroma is most often accomplished by surgical removal utilizing curettage, enucleation, or excision. Even though the teeth may be unaffected, there can be migration and loosening of adjacent teeth by tumor invasion. Therefore, the adjacently involved teeth of poor prognosis should be extracted to eliminate any possible tumor remnants. Overall, the prognosis is good and recurrence rate is considered low. However, Eversole et al [2] reported a recurrence rate as high as 28% following surgical curettage of these lesions. If this happens, complete excision becomes necessary. A variant of ossifying fibroma, the juvenile ossifying fibroma, has been described in children and teenagers. This rare lesion behaves in a more aggressive fashion than the ossifying fibroma, and may require more extensive therapy when encountered [1] . Healing of exposed bone by secondary intention may involve several weeks and cause more wound contraction and scar formation. Collagen products have often been utilized as major components of artificial tissue substitutes, which have to be biocompatible and biodegradable, after the damaged tissue has regenerated and healed. Recently, artificial collagen grafts have been used in the repair of soft tissue defects or burn wounds, as temporary skin substitutes. Nevertheless, it has been reported that the survival of autogenous skin grafts on bone lacking periosteum has been poor. Stallings et al [6] found a 22% average skin graft attachment to bare bone compared with a 77% attachment on bone with periosteum. It was considered that the intact vascularized bed is a crucial requirement in ensuring the success of the autogenous skin graft.
Terudermis™ (Terumo Corp.) is a bilayer artificial graft, which comprises an outer layer of silicone and an inner spongy layer of collagen. The bilayer artificial skin consists of a complex of collagen and chondroitin sulfate (glucosaminoglycans). Its antigenicity has been modified in order to reduce the inflammatory response and increase cellular affinity. Osaki et al [7] presented the histologic evidence to demonstrate the advantage of applying artificial collagen sponge (Terudermis™) on experimental dermoperiosteal scalp defects in rabbits. Microscopically, many cells, mainly fibroblasts and capillary vessels, invaded the collagenous implant migrating from the adjacent healthy dermis and the edge of the periosteal wound during healing. These results confirmed clinically that Terudermis™ is effective for the treatment of deep dermoperiosteal defects, in which skin regeneration rarely takes place with conventional therapy such as split-thickness skin grafts. In order to avoid the occurrence of postoperative shallow vestibular depth, Terudermis™ was applied as mentioned in this case report. We found that the postoperative course was unremarkable and the repair was effective on bare bone. During 6 years of postoperative followup, the vestibular depth was enough for dental prosthetics and oral hygiene was easy to maintain. This report described a solution for the surgical repair of a bare bony defect after tumor resection in the jaws.
